JBJonathan J. Bauer-Erickson

Jonathan J. Bauer-Erickson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonathan J. Bauer-Erickson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew P. Norwood

    Interdisciplinary Biomedical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    1 shared publication
  • Brenda M. Gannon

    Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    1 shared publication
  • Jeffrey T. Alliston

    Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    1 shared publication
  • Mahmoud I. Khalil

    Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    1 shared publication
  • Michael D. Berquist

    Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, United States of America

    1 shared publication
  • Mohamed H. Kamel

    Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    1 shared publication

Latest Publications

  • Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra

    by Mahmoud I. Khalil, Jeffrey T. Alliston, Jonathan J. Bauer-Erickson, Rodney Davis, Nabil K. Bissada, Mohamed H. Kamel

    The impact of radical surgery for urothelial carcinoma is significant on patient's quality of life. Organ-sparing surgery (OSS) can provide comparable oncological outcomes and with improved quality of life. In this review, we summarize the indications, techniques and outcomes of OSS for these tumors. PubMed® was searched for relevant articles. Keywords used were: for upper tract urothelial carcinoma (UTUC): endoscopic, ureteroscopic/percutaneous management, laser ablation; for urothelial bladder cancer: bladder preservation, trimodal therapy, muscle invasive bladder cancer (MIBC); for urethral cancer: urethra/penile-sparing, urethral carcinoma. Kidney-sparing surgery is an option in patients with low-risk UTUC with better renal function preservation and comparable oncological control to radical nephroureterectomy. In select patients with MIBC, trimodal therapy has better quality of life and comparable oncological control to radical cystectomy. In distal male urethral cancer, penile conserving surgery is feasible and offers acceptable survival outcomes. In female urethral cancer, organ preservation can be achieved, in addition to OSS, through radiation. In the appropriately selected patient, OSS in upper tract, bladder and urethral carcinoma has comparable oncological outcomes to radical surgery and with the additional benefit of improved quality of life.


  • Phencyclidine-like in vivo effects of methoxetamine in mice and rats

    by Michael D. Berquist, William S. Hyatt, Jonathan Bauer-Erickson, Brenda M. Gannon, Andrew P. Norwood, William E. Fantegrossi